lansoprazole has been researched along with Multiple Organ Failure in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candar, M | 1 |
| Gunes, H | 1 |
| Boz, BV | 1 |
| Kandis, H | 1 |
| Kutlucan, L | 1 |
| Saritas, A | 1 |
1 other study available for lansoprazole and Multiple Organ Failure
| Article | Year |
|---|---|
Asystole after the first dose of lansoprazole.
Topics: Adult; Anaphylaxis; Drug Hypersensitivity; Fatal Outcome; Female; Heart Arrest; Humans; Lansoprazole | 2014 |